Page last updated: 2024-12-07

saccharolactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

saccharolactone: used as index for assessing induction of hepatic enzymes by anticonvulsants; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

D-glucaro-1,4-lactone : A delta-lactone that is D-glucono-1,4-lactone in which the hydroxy group at position 6 has been oxidised to the corresponding carboxylic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID122306
CHEMBL ID1808316
CHEBI ID85805
SCHEMBL ID515325
MeSH IDM0053683

Synonyms (35)

Synonym
5027-63-4
unii-7vd5u57bab
7vd5u57bab ,
d-(tetrahydro-2,3,4-trihydroxy-5-oxofuran-2-yl)glycollic acid
einecs 206-865-2
saccharolactone, d-
d-saccharic acid 1,4-lactone
saccharolactone
E5B5931F-018A-4618-8613-7E44512278FE
glucaric acid-1,4-lactone
389-36-6
(2s)-2-[(2s,3r,4r)-3,4-dihydroxy-5-oxooxolan-2-yl]-2-hydroxyacetic acid
AKOS006282818
chebi:85805 ,
CHEMBL1808316
d-glucaric acid, 1,4-lactone
1,4-d-glucarolactone
d-glucaro-1,4-lactone
glucaric acid, 1,4-lactone
1,4-glucarolactone
SCHEMBL515325
glucaric acid-3,6-lactone
glucaro-1,4-lactone
saccharo-1,4-lactone
d-saccharolactone
d-glucaric acid 1,4-lactone [mi]
d-glucaric acid-1,4-lactone
W-203286
(2s)-[(2s,3r,4r)-3,4-dihydroxy-5-oxotetrahydrofuran-2-yl](hydroxy)acetic acid
bdbm50008907
C21095
Q27158734
(s)-2-((2s,3r,4r)-3,4-dihydroxy-5-oxotetrahydrofuran-2-yl)-2-hydroxyacetic acid
saccharic acid 1,4-lactone
DTXSID201311466

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
", enterohepatic, enteric and local recycling) plays a central role in governing the disposition of phenolics such as flavonoids, resulting in low systemic bioavailability but higher gut bioavailability and longer than expected apparent half-life."( Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids.
Dai, P; Hu, M; Li, Q; Liu, Z; Lu, L; Luo, F; Wang, L; Wang, X; Wang, Y; Zhu, L, 2015
)
0.42

Dosage Studied

ExcerptRelevanceReference
" The conventional urines exceeded the germ-free urines by 10-fold in their content of 6-hydroxy-1-acetamidopyrene (NAAP-6-OH), previously identified as the predominant contributor to the mutagenicity of the urines of rats dosed with NP and excreted mainly as its beta-glucuronide conjugate."( Formation of mutagenic urinary metabolites from 1-nitropyrene in germ-free and conventional rats: role of the gut flora.
Ball, LM; Gustafsson, BE; Gustafsson, JA; Kohan, MJ; Lewtas, J; Rafter, JJ, 1991
)
0.28
" The efficacy of MMF as an immunosuppressant and long-term safety in cats of this dosage regimen is unknown."(
Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
delta-lactoneA lactone having a six-membered lactone ring.
aldarolactoneA carbohydrate lactone resulting from the formal intramolecular condensation between a hydroxy group and one of the carboxy groups of an aldaric acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-glucuronidase Bos taurus (cattle)IC50 (µMol)48.39711.10002.66504.2300AID1129460; AID1254382; AID1292003; AID1309248; AID1433719; AID1501755; AID607799
Beta-glucuronidaseHomo sapiens (human)IC50 (µMol)47.43640.02003.08337.4000AID1153850; AID1165427; AID1230052; AID1306825; AID1494144; AID1545107; AID1568737; AID1656436; AID1667339; AID1755844; AID1802587
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (9)

Processvia Protein(s)Taxonomy
carbohydrate metabolic processBeta-glucuronidase Bos taurus (cattle)
glycosaminoglycan catabolic processBeta-glucuronidase Bos taurus (cattle)
receptor-mediated endocytosisBeta-glucuronidase Bos taurus (cattle)
pinocytosisBeta-glucuronidase Bos taurus (cattle)
endosome to lysosome transportBeta-glucuronidase Bos taurus (cattle)
carbohydrate metabolic processBeta-glucuronidaseHomo sapiens (human)
glycosaminoglycan catabolic processBeta-glucuronidaseHomo sapiens (human)
heparan sulfate proteoglycan catabolic processBeta-glucuronidaseHomo sapiens (human)
chondroitin sulfate catabolic processBeta-glucuronidaseHomo sapiens (human)
hyaluronan catabolic processBeta-glucuronidaseHomo sapiens (human)
glucuronoside catabolic processBeta-glucuronidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
signaling receptor bindingBeta-glucuronidase Bos taurus (cattle)
beta-glucuronidase activityBeta-glucuronidaseHomo sapiens (human)
signaling receptor bindingBeta-glucuronidaseHomo sapiens (human)
protein domain specific bindingBeta-glucuronidaseHomo sapiens (human)
carbohydrate bindingBeta-glucuronidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
lysosomeBeta-glucuronidase Bos taurus (cattle)
cell surfaceBeta-glucuronidase Bos taurus (cattle)
membraneBeta-glucuronidase Bos taurus (cattle)
extracellular regionBeta-glucuronidaseHomo sapiens (human)
extracellular spaceBeta-glucuronidaseHomo sapiens (human)
membraneBeta-glucuronidaseHomo sapiens (human)
azurophil granule lumenBeta-glucuronidaseHomo sapiens (human)
lysosomal lumenBeta-glucuronidaseHomo sapiens (human)
intracellular membrane-bounded organelleBeta-glucuronidaseHomo sapiens (human)
extracellular exosomeBeta-glucuronidaseHomo sapiens (human)
ficolin-1-rich granule lumenBeta-glucuronidaseHomo sapiens (human)
extracellular spaceBeta-glucuronidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (29)

Assay IDTitleYearJournalArticle
AID611697Inhibition of Escherichia coli beta-glucuronidase assessed as inhibition of p-nitrophenyl-beta-D-glucuronide hydrolysis preincubated for 30 mins measured 30 mins after substrate addition by spectrophotometry2011Journal of natural products, Jun-24, Volume: 74, Issue:6
Isoflavone dimers and other bioactive constituents from the figs of Ficus mucuso.
AID1494144Inhibition of human beta-glucuronidase2018European journal of medicinal chemistry, Jan-01, Volume: 143Synthesis of bis-indolylmethanes as new potential inhibitors of β-glucuronidase and their molecular docking studies.
AID1292003Inhibition of bovine beta-glucuronidase assessed as p-nitrophenol formation preincubated for 30 mins followed by addition of p-nitrophenyl-beta-D-glucuronide by spectrophotometric analysis2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
Thiadiazole derivatives as New Class of β-glucuronidase inhibitors.
AID1667339Inhibition of beta-glucuronidase (unknown origin) using p-nitrophenyl-beta-D-glucuronide as substrate pre-incubated for 30 mins followed by substrate addition by spectrophotometric method2020Bioorganic & medicinal chemistry, 04-01, Volume: 28, Issue:7
One-pot synthesis of thioxo-tetrahydropyrimidine derivatives as potent β-glucuronidase inhibitor, biological evaluation, molecular docking and molecular dynamics studies.
AID1165427Inhibition of beta-glucuronidase (unknown origin) using p-nitrophenyl-beta-D-glucuronide substrate incubated for 30 mins by spectrophotometry2014Bioorganic & medicinal chemistry, Dec-01, Volume: 22, Issue:23
Substituted thieno[2,3-b]thiophenes and related congeners: Synthesis, β-glucuronidase inhibition activity, crystal structure, and POM analyses.
AID1153850Inhibition of beta-glucuronidase activity (unknown origin) assessed as p-nitrophenol formation after 30 mins using p-nitrophenyl-beta-D-glucuronide as substrate by spectrophotometry2014Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13
Synthesis and β-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones.
AID611701Inhibition of Escherichia coli beta-glucuronidase assessed as inhibition of p-nitrophenyl-beta-D-glucuronide hydrolysis at 0.05 mM preincubated for 30 mins measured 30 mins after substrate addition by spectrophotometry2011Journal of natural products, Jun-24, Volume: 74, Issue:6
Isoflavone dimers and other bioactive constituents from the figs of Ficus mucuso.
AID1471878Inhibition of N-terminal His-tagged Escherichia coli beta-glucuronidase expressed in Escherichia coli BL21 (DE3) using pNPG as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr2017Journal of medicinal chemistry, 11-22, Volume: 60, Issue:22
Specific Inhibition of Bacterial β-Glucuronidase by Pyrazolo[4,3-c]quinoline Derivatives via a pH-Dependent Manner To Suppress Chemotherapy-Induced Intestinal Toxicity.
AID1757082Inhibition of Escherichia coli beta-glucosidase expressed in Escherichia coli BL21 (DE3) assessed as reduction in PNP formation using beta-PNPG as substrate incubated for 30 mins2021European journal of medicinal chemistry, Apr-15, Volume: 2162,5-Disubstituted furan derivatives containing 1,3,4-thiadiazole moiety as potent α-glucosidase and E. coli β-glucuronidase inhibitors.
AID1757081Inhibition of recombinant Escherichia coli beta-glucosidase expressed in Escherichia coli BL21(DE3) assessed as reduction in PNP formation at 10 uM using beta-PNPG as substrate incubated for 30 mins relative to control2021European journal of medicinal chemistry, Apr-15, Volume: 2162,5-Disubstituted furan derivatives containing 1,3,4-thiadiazole moiety as potent α-glucosidase and E. coli β-glucuronidase inhibitors.
AID1757087Mixed inhibition of recombinant Escherichia coli beta-glucosidase expressed in Escherichia coli BL21(DE3) using beta-PNPG as substrate incubated for 30 mins by Lineweaver-Burk plot analysis2021European journal of medicinal chemistry, Apr-15, Volume: 2162,5-Disubstituted furan derivatives containing 1,3,4-thiadiazole moiety as potent α-glucosidase and E. coli β-glucuronidase inhibitors.
AID1433719Inhibition of bovine liver beta glucuronidase using p-nitrophenyl-beta-D-glucuronide as substrate preincubated for 30 mins followed by substrate addition by spectrophotometric method2017European journal of medicinal chemistry, Jan-05, Volume: 125Biology-oriented drug synthesis (BIODS): In vitro β-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives.
AID1129460Inhibition of bovine liver beta-glucuronidase using p-nitrophenyl-beta-D-glucuronide as substrate after 30 mins by spectrophotometry2014Bioorganic & medicinal chemistry letters, Apr-01, Volume: 24, Issue:7
Evaluation of bisindole as potent β-glucuronidase inhibitors: synthesis and in silico based studies.
AID1471877Inhibition of N-terminal His-tagged human beta-glucuronidase expressed in Escherichia coli BL21 (DE3) assessed as residual activity using pNPG as substrate at 10 uM preincubated for 30 mins followed by substrate addition measured after 1 hr relative to co2017Journal of medicinal chemistry, 11-22, Volume: 60, Issue:22
Specific Inhibition of Bacterial β-Glucuronidase by Pyrazolo[4,3-c]quinoline Derivatives via a pH-Dependent Manner To Suppress Chemotherapy-Induced Intestinal Toxicity.
AID1656463Inhibition of bovine liver beta-glucuronidase using p-nitrophenyl-beta-D-glucuronide as substrate after 30 mins2020European journal of medicinal chemistry, Feb-01, Volume: 187Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.
AID1306825Inhibition of beta-glucuronidase (unknown origin) using p-nitrophenyl-beta-D-glucuronide as substrate assessed as formation of p-nitrophenol incubated for 30 mins by spectrophotometric analysis2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and biological evaluation of novel N-arylidenequinoline-3-carbohydrazides as potent β-glucuronidase inhibitors.
AID1755844Inhibition of beta-glucuronidase (unknown origin) using p-nitrophenyl-beta-D-glucuronide as substrate pre-incubated for 30 mins followed by substrate addition by absorbance method2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID1501755Inhibition of bovine liver beta-glucuronidase using p-nitrophenyl-beta-D-glucuronide as substrate preincubated for 30 mins followed by substrate addition by spectrophotometric analysis2017European journal of medicinal chemistry, Oct-20, Volume: 139Synthesis, in vitro β-glucuronidase inhibitory potential and molecular docking studies of quinolines.
AID1568737Inhibition of beta-glucuronidase (unknown origin) using p-nitrophenyl-beta-D-glucuronide as substrate after 30 mins by spectrophotometric analysis2019European journal of medicinal chemistry, Sep-15, Volume: 178Medicinal prospects of antioxidants: A review.
AID1471876Inhibition of N-terminal His-tagged Escherichia coli beta-glucuronidase expressed in Escherichia coli BL21 (DE3) assessed as residual activity using pNPG as substrate at 10 uM preincubated for 30 mins followed by substrate addition measured after 1 hr rel2017Journal of medicinal chemistry, 11-22, Volume: 60, Issue:22
Specific Inhibition of Bacterial β-Glucuronidase by Pyrazolo[4,3-c]quinoline Derivatives via a pH-Dependent Manner To Suppress Chemotherapy-Induced Intestinal Toxicity.
AID1656436Inhibition of beta-glucuronidase (unknown origin)2020European journal of medicinal chemistry, Feb-01, Volume: 187Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.
AID1254382Inhibition of bovine liver beta-glucuronidase using p-nitrophenyl-beta-D-glucuronide as substrate assessed as p-nitrophenol formation after 30 mins by multiplate reader analysis2015Bioorganic & medicinal chemistry, Dec-01, Volume: 23, Issue:23
Synthesis of novel benzohydrazone-oxadiazole hybrids as β-glucuronidase inhibitors and molecular modeling studies.
AID1309248Inhibition of bovine liver beta-glucuronidase assessed as p-nitrophenol formation preincubated for 30 mins followed by p-nitrophenyl-beta-D-glucuronide addition by spectrophotometric method2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Dihydropyrimidones: As novel class of β-glucuronidase inhibitors.
AID1545107Inhibition of human beta-glucuronidase pre-incubated for 30 mins before p-nitrophenyl-beta-D-glucuronide substrate addition by spectrophotometry2019Bioorganic & medicinal chemistry, 07-15, Volume: 27, Issue:14
Synthesis of oxadiazole-coupled-thiadiazole derivatives as a potent β-glucuronidase inhibitors and their molecular docking study.
AID607799Inhibition of bovine liver beta glucuronidase assessed as p-nitrophenol formation after 30 mins by spectrophotometric method2011Bioorganic & medicinal chemistry, Jul-15, Volume: 19, Issue:14
Synthesis of novel inhibitors of β-glucuronidase based on benzothiazole skeleton and study of their binding affinity by molecular docking.
AID1230052Inhibition of beta-D-glucuronidase (unknown origin) assessed as reduction in p-nitrophenol formation using p-nitrophenyl-beta-D-glucuronide substarte incubated at 37 degC for 30 mins by spectrophotometric method2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: a new class of β-glucuronidase inhibitors and in silico studies.
AID1656440Inhibition of Escherichia coli K-12 beta-glucuronidase using PNPG as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins2020European journal of medicinal chemistry, Feb-01, Volume: 187Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.
AID1802580β-Glucuronidase Inhibition Assay from Article 10.1016/j.bioorg.2016.12.011: \\Synthesis, in vitro u00DF-glucuronidase inhibitory activity and in silico studies of novel (E)-4-Aryl-2-(2-(pyren-1-ylmethylene)hydrazinyl)thiazoles.\\2017Bioorganic chemistry, 02, Volume: 70Synthesis, in vitro β-glucuronidase inhibitory activity and in silico studies of novel (E)-4-Aryl-2-(2-(pyren-1-ylmethylene)hydrazinyl)thiazoles.
AID1802587β-Glucuronidase Assay from Article 10.1016/j.bioorg.2017.01.015: \\Synthesis and in silico studies of novel sulfonamides having oxadiazole ring: As u00DF-glucuronidase inhibitors.\\2017Bioorganic chemistry, 04, Volume: 71Synthesis and in silico studies of novel sulfonamides having oxadiazole ring: As β-glucuronidase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (79)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (18.99)18.7374
1990's11 (13.92)18.2507
2000's6 (7.59)29.6817
2010's42 (53.16)24.3611
2020's5 (6.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (7.23%)6.00%
Case Studies1 (1.20%)4.05%
Observational0 (0.00%)0.25%
Other76 (91.57%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]